Imaging Decisions Start Here SM
|
|
- Lily Ball
- 5 years ago
- Views:
Transcription
1 Owing to its high resolution and wide anatomic coverage, dynamic first-pass perfusion 320-detector-row CT outperforms PET/CT for distinguishing benign from malignant lung nodules, researchers from Japan report in Radiology. The technique could potentially facilitate patient management by reducing the frequency of negative biopsies. "Ideally, the goals of diagnosis and management are to promptly perform surgery in all patients with operable malignant nodules and to avoid unnecessary thoracotomy in those patients with benign lesions," wrote Yoshiharu Ohno, MD, PhD, and colleagues from Kobe University, Yamanashi University, and Toshiba Medical Systems in Radiology (February 2011, Vol. 258:2, pp ). "Therefore, the ability to distinguish benign from malignant nodules accurately and in the least invasive manner possible is essential." Benign and malignant nodules are thought to have distinctly different physiologic, metabolic, and pharmacokinetic characteristics, and attempts to distinguish the two have been performed in a variety of ways, from CT to dynamic MRI to PET or combined F-18 FDG-PET/CT. According to the authors, dynamic wide-area CT may be well suited to detecting some unique properties of malignant nodules. Nodule perfusion and extraction fraction values from dynamic first-pass 320-detector-row CT may help radiologists distinguish malignant from benign pulmonary nodules more effectively than the quantitative blood volumes calculated from the same data, as well as the FDG uptake assessment at combined PET/CT, the authors stated. Although promising results have been reported with PET/CT and MRI, "a substantial portion of nodules detected with them are false negative and/or false positive," they wrote. The prospective study aimed to assess the capabilities of quantitative first-pass perfusion 320-detector-row CT for distinguishing benign from malignant nodules compared to PET/CT. The cohort included 50 consecutive patients (mean age, 73.3 years ± 8.6) with 76 pulmonary nodules (mean diameter, 15.9 mm ± 7.7; diameter range, 4-29 mm). All patients underwent dynamic area-detector CT, PET/CT, and microbacterial and/or histopathologic exams. Dynamic area-detector CT examinations were performed with a 320-detector-row CT scanner (Aquilion One, Toshiba Medical Systems) using volumetric cine scanning without helical imaging.
2 page 2 Based on histopathologic results, the 76 pulmonary nodules in the cohort were categorized into three groups: 1. Benign nodules with low biologic activity (n = 6) 2. Benign nodules with high biologic activity (n= 27) 3. Malignant nodules (n = 43) The 43 malignant nodules consisted of 40 peripheral lung cancers (30 adenocarcinomas with mixed types of bronchioloalveolar carcinomas [BACs] and other subtypes, including acinar, papillary, or solid adenocarcinomas; five localized BACs; two adenocarcinomas without mixed subtypes; and three squamous cell carcinomas) and three metastatic lung tumors consisting of two colon cancers and one thyroid cancer. The six benign nodules with expected low biologic activity consisted of four tuberculomas and two hamartomas. The 27 benign nodules with expected high biologic activity included 21 organizing pneumonias, four atypical Mycobacterium infections, one case of aspergillosis, and one case of cryptococcosis. For each CT dataset, the authors calculated the perfusion in each nodule derived using the maximum slope model (PFMS). Then the extraction fraction was derived using the Patlak plot model (EFPP). Next, blood volume was calculated using the Patlak plot model (BVPP). Finally, the nodule parameters were compared statistically among the three nodule groups. "Our study results show significant and reproducible differences in [maximal standard uptake value (SUVmax)] and in all of the evaluated dynamic first-pass area-detector CT indexes among the malignant nodules, benign nodules with expected low biologic activity, and benign nodules with expected high biologic activity," Ohno and colleagues reported. "In addition, dynamic first-pass area-detector CT enabled more specific and accurate differentiation between the malignant and benign pulmonary nodule groups than did PET/ CT." All indexes in the malignant nodule group were significantly different from those in the low-biologic-activity benign nodule group (p < 0.05). Areas under the receiver operator characteristics (ROC) curve for PFMS and EF PP were significantly larger than those for BVPP (p < 0.05) and SUVmax (p < 0.05). Significant differences were also found between benign and malignant nodules in two dynamic area-detector CT indexes: PFMS and EFPP.
3 page 3 The specificity and accuracy of PFMS (79% and 90%, respectively) and EFPP (82% and 86%, respectively) were significantly higher than those of both blood volume (BVPP: 54% and 72%, respectively) and standardized uptake value (SUVmax: 52% and 74%, respectively) (p < 0.05). Comparisons among all of the perfusion indexes evaluated by maximum slope and Patlak plot analyses of dynamic wide-area CT and PET/CT SUVmax data revealed significant correlations with each other. And the reproducibility coefficients for all of the indexes evaluated in the study were consistent with those of previous studies, the group noted. Axial images of primary lung cancer (adenocarcinoma) in left upper lung lobe in 76-year-old man. Above, thin-section CT image shows nodule 18 mm in diameter in left upper lobe. Below, perfusion map shows nodule has high perfusion, with PFMS (scale at left) determined to be 89.9 ml/100 ml/min; this is a true-positive case according to maximal slope method results. Bottom, integrated PET/CT image shows high uptake of FDG, with SUVmax of lesion determined to be 3.8, indicating a true-positive case. Images republished with permission of the Radiological Society of North America from Radiology, February 2011, Vol. 258:2, pp
4 page 4 The correlations held for every measurement parameter and every nodule type. All 320-detector-row wide-area CT indexes, as well as SUV max, were significantly different from the malignant nodules, both including and excluding bronchoalveolar-cell carcinomas and benign nodules with expected low biologic activity, Ohno and colleagues reported.
5 page 5 "Comparisons of the diagnostic capability of the dynamic area-detector CT indexes and the SUVmax demonstrated that PFMS and EFPP enabled significantly more specific and accurate differentiation than did BVPP and SUVmax," Ohno and colleagues wrote. "These results suggest that dynamic area-detector CT with use of blood flow parameters such as the PFMS and EFPP rather than the BVPP in a nodule can be used to more precisely and accurately analyze an increase in tumor angiogenesis, which induces tumor perfusion and microvascular density, the extracellular space and permeability surface of capillaries, and the extraction fraction of malignant tumors." They credited use of 320-detector-row dynamic first-pass CT to enabling more specific and accurate differentiation between the malignant and benign pulmonary nodule groups than PET/CT. The wide-area CT system can also be used to evaluate time-attenuation curves for several pulmonary nodules located within a 16-cm area and in the main trunk of the pulmonary artery, important for quantitative analysis of the blood flow pattern with use of maximum slope and Patlak plot methods at the same time. Significantly moderate correlations were found between the dynamic area-detector CT indexes and the SUVmax measurements. These blood-flow parameters can improve precision and accuracy in distinguishing benign from malignant nodules compared to FDG uptake assessment "because they show enhanced expression of glucose transporter messenger RNA to result in an increase in glucose transport protein in malignant tumors," the authors wrote. In routine practice with the wide-area scanner, nodule PFMS represents the single most effective marker for distinguishing benign from malignant nodules -- including those with low and high expected biologic activity. This information "could help physicians provide immediate treatment for patients with malignant nodules and help avoid surgery or further intervention for patients without malignant nodules," they wrote. Limitations of the study include a large percentage (57%) of malignant nodules 30 mm or smaller, and a relatively large mean lesion size (15.9 mm ± 7.7). Patients were selected according to nodule criteria, introducing selection bias. The radiation dose needs to be reduced further and new tools are needed to accomplish this, they added. "One might wonder whether, with use of the described recently developed area-detector CT system, the patients received unnecessary radiation on the basis of the size and the number of multiple nodules and the distance between the main trunk of the pulmonary artery and the nodules," the authors wrote. "This is because the detector collimation of current area-detector CT systems is not changeable for dynamic first-pass perfusion CT examinations and each scan always encompasses a 16-cm z-axis area."
6 page 6 The detector collimation for dynamic area-detector CT should be changeable according to the size and number of nodules and the distance between the main trunk of the pulmonary artery and the nodules to reduce the dose. "In conclusion, dynamic first-pass area-detector perfusion CT might be more specific and accurate than integrated FDG-PET/CT in the differentiation of malignant and benign pulmonary nodules," Ohno and colleagues wrote. "Dynamic area-detector CT also might complement integrated FDG-PET/CT in the management of pulmonary nodules." Copyright 2011 AuntMinnie.com
PET/CT Frequently Asked Questions
PET/CT Frequently Asked Questions General Q: Is FDG PET specific for cancer? A: No, it is a marker of metabolism. In general, any disease that causes increased metabolism can result in increased FDG uptake
More informationCT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationI appreciate the courtesy of Kusumoto at NCC for this presentation. What is Early Lung Cancers. Early Lung Cancers. Early Lung Cancers 18/10/55
I appreciate the courtesy of Kusumoto at NCC for this presentation. Dr. What is Early Lung Cancers DEATH Early period in its lifetime Curative period in its lifetime Early Lung Cancers Early Lung Cancers
More informationLung Perfusion Analysis New Pathways in Lung Imaging. Case Study Brochure PLA 309 Hospital
Lung Perfusion Analysis New Pathways in Lung Imaging Case Study Brochure PLA 309 Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2012 all rights reserved. Design and specifications
More informationPET/CT in lung cancer
PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of
More informationThoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis
19 th Congress of APSR PG of Lung Cancer (ESAP): Update of Lung Cancer Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis Kazuma Kishi, M.D. Department of Respiratory Medicine,
More informationLiver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.
New Frontiers in Dynamic Volume Imaging dynamic volume CT Case Study Brochure Chang Gung Memorial Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2010-2011. All rights
More informationOptimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital
Optimized propels high utilization of PET/MR at Pitié-Salpêtrière Hospital clinical pathway As one of Europe s largest teaching hospitals, Pitié-Salpêtrière Hospital is renowned for its innovative research
More informationComparison of three mathematical prediction models in patients with a solitary pulmonary nodule
Original Article Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule Xuan Zhang*, Hong-Hong Yan, Jun-Tao Lin, Ze-Hua Wu, Jia Liu, Xu-Wei Cao, Xue-Ning Yang From
More informationSmall Pulmonary Nodules: Our Preliminary Experience in Volumetric Analysis of Doubling Times
Small Pulmonary Nodules: Our Preliminary Experience in Volumetric Analysis of Doubling Times Andrea Borghesi, MD Davide Farina, MD Roberto Maroldi, MD Department of Radiology University of Brescia Brescia,
More informationMEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES
MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES Although response is not the primary endpoint of this trial, subjects with measurable disease will be assessed by standard criteria. For the purposes of this
More informationLung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09
Lung Cancer Imaging Terence Z. Wong, MD,PhD Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Acknowledgements Edward F. Patz, Jr., MD Jenny Hoang, MD Ellen L. Jones, MD, PhD Lung
More informationobjectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University
objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand
More informationLUNG NODULES: MODERN MANAGEMENT STRATEGIES
Department of Radiology LUNG NODULES: MODERN MANAGEMENT STRATEGIES Christian J. Herold M.D. Department of Biomedical Imaging and Image-guided Therapy Medical University of Vienna Vienna, Austria Pulmonary
More informationFDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave
FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.
More informationNoninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index
doi: 10.5761/atcs.oa.14-00241 Original Article Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index Satoshi Shiono, MD, 1 Naoki Yanagawa, MD, 2 Masami Abiko,
More informationEvidence based approach to incidentally detected subsolid pulmonary nodule. DM SEMINAR July 27, 2018 Harshith Rao
Evidence based approach to incidentally detected subsolid pulmonary nodule DM SEMINAR July 27, 2018 Harshith Rao Outline Definitions Etiologies Risk evaluation Clinical features Radiology Approach Modifications:
More informationLow-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2
Low-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2 The Committee for Management of CT-screening-detected Pulmonary Nodules 2009-2011 The Japanese Society of CT Screening
More informationPositron Emission Tomography in Lung Cancer
May 19, 2003 Positron Emission Tomography in Lung Cancer Andrew Wang, HMS III Patient DD 53 y/o gentleman presented with worsening dyspnea on exertion for the past two months 30 pack-year smoking Hx and
More informationThe latest developments - Automated Breast Volume Scanning. Dr. med. M. Golatta
The latest developments - Automated Breast Volume Scanning Dr. med. M. Golatta Automated Breast Volume US: Why? o Mammography is limited in dense breasts: high false negative rate o Many of these tumors
More informationUtility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer
Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department
More informationDisclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None
What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department
More informationAn Introduction to PET Imaging in Oncology
January 2002 An Introduction to PET Imaging in Oncology Janet McLaren, Harvard Medical School Year III Basics of PET Principle of Physiologic Imaging: Allows in vivo visualization of structures by their
More informationWhat to Do with Small Lung Nodules Hanh Vu Nghiem, MD William Beaumont Hospital Royal Oak, Michigan
What to Do with Small Lung Nodules Hanh Vu Nghiem, MD William Beaumont Hospital Royal Oak, Michigan Small Lung Nodules What to do with small lung nodules? We biopsy them when requested What are our accuracy
More informationApproach to Pulmonary Nodules
Approach to Pulmonary Nodules Edwin Jackson, Jr., DO Assistant Professor-Clinical Director, James Early Detection Clinic Department of Internal Medicine Division of Pulmonary, Allergy, Critical Care and
More informationThe Spectrum of Management of Pulmonary Ground Glass Nodules
The Spectrum of Management of Pulmonary Ground Glass Nodules Stanley S Siegelman CT Society 10/26/2011 No financial disclosures. Noguchi M et al. Cancer 75: 2844-2852, 1995. 236 surgically resected peripheral
More informationBreast Cancer PET/CT Imaging Protocol
Breast Cancer PET/CT Imaging Protocol Scanning Protocol: Patients are scanned from the top of the neck through the pelvis. Arms-up position is used to avoid beam-hardening artifact in the chest and abdomen.
More informationPET CT for Staging Lung Cancer
PET CT for Staging Lung Cancer Rohit Kochhar Consultant Radiologist Disclosures Neither I nor my immediate family members have financial relationships with commercial organizations that may have a direct
More informationFunctional aspects of anatomical imaging techniques
Functional aspects of anatomical imaging techniques Nilendu Purandare Associate Professor & Consultant Radiologist Tata Memorial Centre Functional/metabolic/molecular imaging (radioisotope scanning) PET
More informationCombined Anatomical and Functional Imaging with Revolution * CT
GE Healthcare Case studies Combined Anatomical and Functional Imaging with Revolution * CT Jean-Louis Sablayrolles, M.D. Centre Cardiologique du Nord, Saint-Denis, France Case 1 Whole Brain Perfusion and
More informationLearning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening
Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context
More informationRadiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh
Radiological staging of lung cancer Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh Bronchogenic Carcinoma Accounts for 14% of new cancer diagnoses in 2012. Estimated to kill ~150,000
More informationThe solitary pulmonary nodule: Assessing the success of predicting malignancy
The solitary pulmonary nodule: Assessing the success of predicting malignancy Poster No.: C-0829 Congress: ECR 2010 Type: Scientific Exhibit Topic: Chest Authors: R. W. K. Lindsay, J. Foster, K. McManus;
More informationU"lity of Screening and Surveillance Using Nuclear Medicine Methodology. (Lung Cancer) Michael M. Graham, PhD, MD University of Iowa
U"lity of Screening and Surveillance Using Nuclear Medicine Methodology (Lung Cancer) Michael M. Graham, PhD, MD University of Iowa American Cancer Society IniBal Guideline Clinicians with access to high-
More informationDeppen S, et al. Annals of Thoracic Surgery 2011;92:
Deppen S, et al. Annals of Thoracic Surgery 2011;92:428-33. http://www.nationmaster.com/graph/ mor_his-mortality-histoplasmosis http://www.humirarems.com/brochure.aspx Baddley, John W., et al. Emerging
More informationDiffuse high-attenuation within mediastinal lymph nodes on non-enhanced CT scan: Usefulness in the prediction of benignancy
Diffuse high-attenuation within mediastinal lymph nodes on non-enhanced CT scan: Usefulness in the prediction of benignancy Poster No.: C-1785 Congress: ECR 2012 Type: Authors: Keywords: DOI: Scientific
More informationGuidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening
Guidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening 1. Introduction In January 2005, the Committee for Preparation of Clinical Practice Guidelines for the Management
More informationRadiology Pathology Conference
Radiology Pathology Conference Sharlin Johnykutty,, MD, Cytopathology Fellow Sara Majewski, MD, Radiology Resident Friday, August 28, 2009 Presentation material is for education purposes only. All rights
More informationPOSITRON EMISSION TOMOGRAPHY (PET)
Status Active Medical and Behavioral Health Policy Section: Radiology Policy Number: V-27 Effective Date: 08/27/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More informationCase Report PET/CT Imaging in Oncology: Exceptions That Prove the Rule
Case Reports in Oncological Medicine Volume 2013, Article ID 865032, 4 pages http://dx.doi.org/10.1155/2013/865032 Case Report PET/CT Imaging in Oncology: Exceptions That Prove the Rule M. Casali, 1 A.
More informationFunctional CT imaging techniques for the assessment of angiogenesis in lung cancer
Perspective Functional CT imaging techniques for the assessment of angiogenesis in lung cancer Thomas Henzler 1, Jingyun Shi 2, Hashim Jafarov 1, Stefan O. Schoenberg 1, Christian Manegold 3, Christian
More informationOBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.
Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management
More informationScreening for Lung Cancer: Are We There Yet?
Screening for Lung Cancer: Are We There Yet? Kavita Garg, MD Professor of Radiology University of CO, Denver Mountain States Cancer Conference Nov 6 th 2010 The Epidemiology of Lung Cancer Tobacco is the
More informationLUNG CANCER continues to rank as the leading cause
1138 IEEE TRANSACTIONS ON MEDICAL IMAGING, VOL. 24, NO. 9, SEPTEMBER 2005 Computer-Aided Diagnostic Scheme for Distinction Between Benign and Malignant Nodules in Thoracic Low-Dose CT by Use of Massive
More informationEvaluation of Lung Cancer Response: Current Practice and Advances
Evaluation of Lung Cancer Response: Current Practice and Advances Jeremy J. Erasmus I have no financial relationships, arrangements or affiliations and this presentation will not include discussion of
More informationPET Guidance of Therapy for BNCT and in vivo B-10 imaging
INFN LNL Legnaro 17-19 Novembre 2009 Principles of Positron Emission Tomography and Radiopharmaceuticals PET Guidance of Therapy for BNCT and in vivo B-10 imaging Luca Menichetti, Ph.D C.N.R. Institute
More information8/10/2016. PET/CT Radiomics for Tumor. Anatomic Tumor Response Assessment in CT or MRI. Metabolic Tumor Response Assessment in FDG-PET
PET/CT Radiomics for Tumor Response Evaluation August 1, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu Anatomic Tumor Response Assessment
More informationBiases affecting tumor uptake measurements in FDG-PET
Biases affecting tumor uptake measurements in FDG-PET M. Soret, C. Riddell, S. Hapdey, and I. Buvat Abstract-- The influence of tumor diameter, tumor-tobackground activity ratio, attenuation, spatial resolution,
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationChapter 6. Hester Gietema Cornelia Schaefer-Prokop Willem Mali Gerard Groenewegen Mathias Prokop. Accepted for publication in Radiology
Chapter 6 Interscan variability of semiautomated volume measurements in intraparenchymal pulmonary nodules using multidetector-row computed tomography: Influence of inspirational level, nodule size and
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS
More informationRole of DE-CT in Oncology
Role of DE-CT in Oncology Dushyant Sahani, M.D Director of CT Associate Professor of Radiology Massachusetts General Hospital Harvard Medical School Email-dsahani@partners.org Disclosure Research Grant
More informationGUIDELINES FOR PULMONARY NODULE MANAGEMENT : RECENT CHANGES AND UPDATES
Venice 2017 GUIDELINES FOR PULMONARY NODULE MANAGEMENT : RECENT CHANGES AND UPDATES Heber MacMahon MB, BCh Department of Radiology The University of Chicago Disclosures Consultant for Riverain Medical
More informationPulmonary nodule detection in PET/CT images: Improved approach using combined nodule detection and hybrid FP reduction
Pulmonary nodule detection in PET/CT images: Improved approach using combined nodule detection and hybrid FP reduction Atsushi Teramoto* a, Hiroshi Fujita b, Yoya Tomita c, Katsuaki Takahashi c, Osamu
More informationTitle: Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression
Author's response to reviews Title: Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression Authors: Shu-Hua Ma (mashuhua6699@sina.com)
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationPET/CT and PET/MR of Cardiac Tumors
PET/CT and PET/MR of Cardiac Tumors Andrew W. Bowman, MD PhD Assistant Professor of Radiology Mayo Clinic Florida NASCI Annual Meeting San Antonio, TX Oct 9, 2017 2017 MFMER slide-1 Disclosures No financial
More informationPULMONARY NODULES AND MASSES : DIAGNOSTIC APPROACH AND NEW MANAGEMENT GUIDELINES. https://tinyurl.com/hmpn2018
PULMONARY NODULES AND MASSES : DIAGNOSTIC APPROACH AND NEW MANAGEMENT GUIDELINES Heber MacMahon MB, BCh Department of Radiology The University of Chicago https://tinyurl.com/hmpn2018 Disclosures Consultant
More informationThe small subsolid pulmonary nodules. What radiologists need to know.
The small subsolid pulmonary nodules. What radiologists need to know. Poster No.: C-1250 Congress: ECR 2016 Type: Educational Exhibit Authors: L. Fernandez Rodriguez, A. Martín Díaz, A. Linares Beltrán,
More informationMolecular Imaging and Cancer
Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000
More informationThe Role of PET / CT in Lung Cancer Staging
July 2004 The Role of PET / CT in Lung Cancer Staging Vlad Vinarsky, Harvard Medical School Year IV Patient AM HPI: 81 yo F p/w hemoptysis x 1 month LLL lesion on CXR, not responsive to Abx 35 pack-year
More informationResearch Article The Advantage of PET and CT Integration in Examination of Lung Tumors
Hindawi Publishing Corporation International Journal of Biomedical Imaging Volume 2007, Article ID 17131, 5 pages doi:10.1155/2007/17131 Research Article The Advantage of PET and CT Integration in Examination
More informationDisclosures. Diffusion and Perfusion Imaging in the Head and Neck. Learning objectives ???
Disclosures No relevant financial disclosures Diffusion and Perfusion Imaging in the Head and Neck Ashok Srinivasan, MD Associate Professor Director of Neuroradiology University of Michigan Health System
More informationF NaF PET/CT in the Evaluation of Skeletal Malignancy
F NaF PET/CT in the Evaluation of Skeletal Malignancy Andrei Iagaru, MD September 26, 2013 School of of Medicine Ø Introduction Ø F NaF PET/CT in Primary Bone Cancers Ø F NaF PET/CT in Bone Metastases
More informationPulmonary Nodules & Masses
Pulmonary Nodules & Masses A Diagnostic Approach Heber MacMahon The University of Chicago Department of Radiology Disclosure Information Consultant for Riverain Technology Minor equity in Hologic Royalties
More informationRadiological Manifestations of Metastatic Melanoma
Radiological Manifestations of Metastatic Melanoma Lia Hojman, Universidad de Chile Year VII Our patient: Clinical Presentation A 24 year old male. Former smoker. 8 months ago, he suffered a burn in his
More informationWith recent advances in diagnostic imaging technologies,
ORIGINAL ARTICLE Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Kwhanmien Kim, MD,* Young Mog
More informationProf. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.
Role of Whole-body Diffusion MR in Detection of Metastatic lesions Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Cancer is a potentially life-threatening disease,
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationGemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis
GE Healthcare Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis CT clinical case study lesion characterization Desiree Morgan, MD Vice Chair of Clinical Research Professor
More informationDr Keerti Gedela. Chelsea and Westminster Hospital NHS Foundation Trust, London. 19 th Annual Conference of the British HIV Association (BHIVA)
19 th Annual Conference of the British HIV Association (BHIVA) Dr Keerti Gedela Chelsea and Westminster Hospital NHS Foundation Trust, London 16-19 April 2013, Manchester Central Convention Complex Value
More informationPET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
More informationTypical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?
Typical PET Image Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? PET/CT Oncology Imaging Anatometabolic fusion images are useful in the management
More informationHRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules
Original Article HRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules Wei Yu 1, Zhaoyu Wang 2, Liyong Qian 2, Shanjun Wang
More informationNuclear Sciences and Medicine
Nuclear Sciences and Medicine Rethy Chhem, MD, PhD (Edu), PhD (His), FRCPC Division of Human Health Guest Professor, Medical University of Vienna International Atomic Energy Agency Medical Imaging X-rays
More informationRadiological assessment of neoadjuvent chemotherapy for breast cancer
XV th Balkan Congress of Radiology Budapest, Hungary, October 12 15, 2017 Radiological assessment of neoadjuvent chemotherapy for breast cancer V. Bešlagić C l i n i c o f R a d i o l o g y, U n i v e
More informationCT PET SCANNING for GIT Malignancies A clinician s perspective
CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset
More informationMolecular Imaging in the Development of Cancer Therapeutics. Johannes Czernin
Molecular Imaging in the Development of Cancer Therapeutics Johannes Czernin Ahmanson Biological Imaging Division University of California Los Angeles Cancer Statistics Cancer Type 5-year Survival Rate
More informationLos Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010
Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted
More informationPre-operative Ultrasound of Lymph Nodes in Thyroid Cancer
Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel
More informationNew Visions in PET: Surgical Decision Making and PET/CT
New Visions in PET: Surgical Decision Making and PET/CT Stanley J. Goldsmith, MD Director, Nuclear Medicine Professor, Radiology & Medicine New York Presbyterian Hospital- Weill Cornell Medical Center
More informationFDG PET/CT in Lung Cancer Read with the experts. Homer A. Macapinlac, M.D.
FDG PET/CT in Lung Cancer Read with the experts Homer A. Macapinlac, M.D. Patient with suspected lung cancer presents with left sided chest pain T3 What is the T stage of this patient? A) T2a B) T2b C)
More informationEarly detection of prostate cancer (PCa) may feasibly lead
ORIGINAL ARTICLE C-11 Choline PET/CT Imaging for Differentiating Malignant From Benign Prostate Lesions Xin Li, MD,* Qi Liu, MD, PhD,* Muwen Wang, MD, PhD,* Xunbo Jin, MD,* Qingwei Liu, MD, PhD,* Shuzhan
More informationImaging of the cisterna chyli on PET-CT in patients with known malignancy: Report of two cases
Imaging of the cisterna chyli on PET-CT in patients with known malignancy: Report of two cases Natalie Burns, B.S., Jason Barksdale, M.D., Linh Ho, M.D., and Patrick M. Colletti, M.D. Citation: Burns N,
More informationImaging Patient Education What you should know about your PET/CT Bone Scan.
Imaging Patient Education What you should know about your PET/CT Bone Scan. Purpose: PET/CT uses a small amount of a radioactive sodium fluoride product to detect cancer within the bones. A low dose CT
More informationROLE OF PET-CT SCAN IN LOCALLY ADVANCED HEAD & NECK CANCER: A Prospective Study
Official publication of Orofacial Chronicle,India www.jhnps.weebly.com ORIGINAL ARTICLE ROLE OF PET-CT SCAN IN LOCALLY ADVANCED HEAD & NECK CANCER: A Prospective Study ABSTRACT: Akheel Mohammad 1, Anuj
More informationEarly Detection of Lung Cancer. Amsterdam March 5 th 2010
Early Detection of Lung Cancer Amsterdam March 5 th 2010 Rob J van Klaveren, MD, PhD Dept. of Pulmonology Erasmus MC Rotterdam, the Netherlands Early Detection and Screening - Questions to be addressed
More informationRole of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective
Role of imaging in RCC From Diagnosis to Treatment: the Radiologist Perspective Diagnosis Staging Follow up Imaging modalities Limitations and pitfalls Duangkamon Prapruttam, MD Department of Therapeutic
More informationHybrid Imaging SPECT/CT PET/CT PET/MRI. SNMMI Southwest Chapter Aaron C. Jessop, MD
Hybrid Imaging SPECT/CT PET/CT PET/MRI SNMMI Southwest Chapter 2014 Aaron C. Jessop, MD Assistant Professor, Department of Nuclear Medicine UT MD Anderson Cancer Center, Houston, Texas Complimentary role
More informationPushing the boundaries: feature extraction from the lung improves pulmonary nodule classification
University of Iowa Iowa Research Online Theses and Dissertations Spring 2016 Pushing the boundaries: feature extraction from the lung improves pulmonary nodule classification Samantha Kirsten Nowik Dilger
More informationOutcomes in the NLST. Health system infrastructure needs to implement screening
Outcomes in the NLST Health system infrastructure needs to implement screening Denise R. Aberle, MD Professor of Radiology and Bioengineering David Geffen School of Medicine at UCLA 1 Disclosures I have
More informationLYMPHATIC DRAINAGE IN THE HEAD & NECK
LYMPHATIC DRAINAGE IN THE HEAD & NECK Like other parts of the body, the head and neck contains lymph nodes (commonly called glands). Which form part of the overall Lymphatic Drainage system of the body.
More informationCT Lung Screening Implementation Challenges: State Based Initiatives
CT Lung Screening Implementation Challenges: State Based Initiatives Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center Co-Director Rescue Lung, Rescue Life Program Co-Chair Massachusetts
More informationCompact Gamma Camera for Detection of Prostate Cancer
Compact Gamma Camera for Detection of Prostate Cancer Presented at: Human Interest Panel Federal Laboratory Consortium Annual Conference Nashville, Tennessee Brookhaven National Laboratory and Hybridyne
More informationColorectal Cancer and FDG PET/CT
Hybrid imaging in colorectal & esophageal cancer Emmanuel Deshayes IAEA WorkShop, November 2017 Colorectal Cancer and FDG PET/CT 1 Clinical background Cancer of the colon and rectum is one of the most
More informationRelationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors
270 ORIGINAL Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors Yoichi Otomi, Hideki Otsuka, Naomi Morita, Kaori Terazawa, Kaori Furutani, Masafumi Harada,
More informationI9 COMPLETION INSTRUCTIONS
The I9 Form is completed for each screening exam at T0, T1, and T2. At T0 (baseline), the I9 documents comparison review of the baseline screen (C2 Form) with any historical images available. At T1 and
More informationMolecular Imaging and Breast Cancer
Molecular Imaging and Breast Cancer Breast cancer forms in tissues of the breast usually in the ducts, tubes that carry milk to the nipple, and lobules, the glands that make milk. It occurs in both men
More information8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.
U. Joseph Schoepf, MD Prof. (h.c.), FAHA, FSCBT-MR, FNASCI, FSCCT Professor of Radiology, Medicine, and Pediatrics Director, Division of Cardiovascular Imaging Consultant for / research support from: Astellas
More informationCan aortic aneurysm growth rate be predicted in clinical practice using 18-fluorodeoxyglucose positron emission tomography (18-FDG PET)?
Can aortic aneurysm growth rate be predicted in clinical practice using 18-fluorodeoxyglucose positron emission tomography (18-FDG PET)? Poster No.: C-1743 Congress: ECR 2011 Type: Authors: Keywords: DOI:
More information